Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular landscaping of cisplatin resistance in cervical cancer
Rahul Bhattacharjee, Tanima Dey, Lamha Kumar, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113345-113345
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
Yang Yang, Lixia Liu, Yu Tian, et al.
Cancer Letters (2024) Vol. 587, pp. 216659-216659
Open Access | Times Cited: 66
Nano‐biotechnology in tumour and cancerous disease: A perspective review
Ambikesh Soni, Manohar Prasad Bhandari, Gagan Kant Tripathi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 6, pp. 737-762
Open Access | Times Cited: 32
Crosstalk between long noncoding RNA and microRNA in Cancer
Rahul Bhattacharjee, Neeraj Prabhakar, Lamha Kumar, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 885-908
Open Access | Times Cited: 32
MiRNA in cervical cancer: Diagnosis to therapy: Systematic review
Hiwot Tezera Endale, Yitbarek Fantahun Mariye, Habtu Kifle Negash, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24398-e24398
Open Access | Times Cited: 11
Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress
Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 508-523
Open Access | Times Cited: 11
SF1: A Standardised Fraction of Clinacanthus nutans That Inhibits the Stemness Properties of Cancer Stem-Like Cells Derived from Cervical Cancer
Faridah Ismail, Yusmazura Zakaria, Muhammad Isa, et al.
Sains Malaysiana (2024) Vol. 53, Iss. 3, pp. 667-679
Open Access | Times Cited: 8
Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies
S Shruthi, K. Bhasker Shenoy
ChemistrySelect (2024) Vol. 9, Iss. 25
Closed Access | Times Cited: 6
Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review
Suleiman Zakari, Nguedia K. Niels, Grace V. Olagunju, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women
Chou‐Yi Hsu, Safia Obaidur Rab, Ahmed Hussein Zwamel, et al.
Gene (2025), pp. 149217-149217
Closed Access
Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights into Breast, Cervical and Lung Cancer
S Kevat, A. Mistry, Naman Oza, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers
Nooshafarin Shirani, N. Abdi, Matin Chehelgerdi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Kexin Yu, S Zhang, Jiali Shen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1362-1362
Open Access
Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research
Nauf Bou Antoun, Hiba-Tun-Noor A. Mahmood, Anthony J. Walker, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1799-1799
Open Access
DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
Mengying Jiang, Yizuo Song, Hejing Liu, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 546-546
Open Access | Times Cited: 13
New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer
George J. Kontoghiorghes
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13990-13990
Open Access | Times Cited: 21
Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance
Zhengye Liu, Zheng Yang, Mourboul Ablise
Bioorganic Chemistry (2024) Vol. 147, pp. 107310-107310
Closed Access | Times Cited: 3
Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP‐J/NRF2/FDX1 pathway
Minjie Zhang, Mengna Shi, Yang Yu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 8, pp. 1449-1466
Closed Access | Times Cited: 3
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer
Liqiong Wang, Xi Zhang, Shuqing Chen, et al.
Translational Oncology (2024) Vol. 49, pp. 102103-102103
Open Access | Times Cited: 3
Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3123-3123
Open Access | Times Cited: 3
ZIP transporters‐regulated Zn2+ homeostasis: A novel determinant of human diseases
Huimei Liu, Lanfang Li, Ruirui Lu
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 2
Homo and heteromultimetallic complexes containing a group 8 transition metal and μ-diphosphine bridging ligands involved in anticancer research: A review
Basile Roufosse, Christi Serbu, Christoph Marschner, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116528-116528
Open Access | Times Cited: 2
Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses
Prashant Chauhan, Sreepoorna Pramodh, Arif Hussain, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway
Yanshan Jin, Qianqian Wu, Shuangjia Pan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117415-117415
Closed Access | Times Cited: 2
BRSK1 confers cisplatin resistance in cervical cancer cells via regulation of mitochondrial respiration
Liu G, Li Li, Dandan Shang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8803-8815
Closed Access | Times Cited: 5
Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach
Noushin Modabber, Sarah Sadat Mahboub, Sahar Khoshravesh, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 10, pp. 2751-2768
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top